Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:09:36 +0200Tue, 02 Jul 2024 15:39:00 +0200Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 61, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/opdivoHuman medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 61, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/opdivoTue, 02 Jul 2024 15:39:00 +0200Human medicineOpdivo : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-3985-aa_en.pdfOpdivo : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/h-3985-aa_en.pdfWed, 08 Dec 2021 00:00:00 +0100Human medicine